相关实验视频
Updated: May 23, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.5K
我们如何最好地支持2型糖尿病患者的胰岛素自我定位:系统性审查和网络元分析
Panitan Pitak1, Kansak Boonpattharatthiti2, Anjana Fuangchan3
1Faculty of Pharmaceutical Sciences, Naresuan University, Phitsanulok, Thailand; Department of Clinical Pharmacy, Nan Hospital, Nan, Thailand.
Diabetes & metabolic syndrome
|April 13, 2025
概括
赋予2型糖尿病 (T2D) 患者胰岛素自标的权力显著改善了HbA1c的降低. 将赋权与剂量或非剂量指导相结合,为血糖控制提供了最大的好处.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 临床研究 临床研究
背景情况:
- 在2型糖尿病 (T2D) 管理中的胰岛素自标效率是可变的.
- 支持策略显著影响患者的治疗结果.
研究的目的:
- 评估不同胰岛素自标配支持策略对T2D患者血糖控制的影响.
- 确定改善HbA1c水平的最佳支持组件.
主要方法:
- 17项随机对照试验 (RCT) 的系统审查和元分析,包括13,528名参与者.
- 干预措施按剂量指导 (DG),非剂量指导 (NDG) 和赋权分类.
- 使用随机效应模型分析的聚合估计;用CINeMA评估证据的确定性.
主要成果:
- 剂量指导与赋权相结合,与通常护理相比,产生了最大的HbA1c降低 (MD-1.20).
- 其他战略也显示出显著的HbA1c降低:NDG/赋权 (-0.97),DG (-0.42) 和NDG (-0.31).
- 在不同策略之间没有观察到严重低血糖风险的显著差异.
结论:
- 将患者赋权整合到胰岛素自标配支持策略中,可以提高HbA1c的降低.
- 与DG或NDG的联合授权对T2D的血糖管理最有效.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
136
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
136
Diabetes: Management and Pharmacotherapy
222
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
222
Diabetes Mellitus: Overview and Type I Subtype
2.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.3K
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K
Oral Hypoglycemic Agents: Biguanides and Glitazones
149
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
149

